TrialLa Radiologia medica2018

Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).

Silvia Scoccianti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.